Hospital Medicine Alert – November 1, 2007
November 1, 2007
View Issues
-
Statin Withdrawal May Lead to Adverse Outcomes in Acute Stroke
Withdrawal of statin therapy in acute ischemic stroke may lead to increases in death and disability. -
Combination Chemotherapy for Unknown Primary
Carcinoma of unknown primary remains a management problem without an established approach demonstrated to prolong survival. In a phase II study, the combination of carboplatin, gemcitabine, and capecitabine was shown to be fairly well tolerated and, for certain subsets, effective in producing transient tumor regression. -
Telemedicine for Stroke: An Idea Whose Time Has Come
Outcomes for treatment of stroke with intravenous tissue plasminogen activator (tPA) were similar at community hospitals supported by telemedicine consultation with stroke experts compared to academic stroke centers. -
Paroxysmal Atrial Fibrillation: A Possible Cause of Stroke?
Long-term monitoring is likely to detect atrial fibrillation in stroke patients with frequent atrial premature beats. -
BNP Levels: Useful in Separating ARDS from CPE?
When used in conjunction with clinical and radiographic data, brain natriuretic peptide levels may provide a non-invasive alternative for distinguishing between ARDS and cardiogenic pulmonary edema in patients with severe hypoxemic respiratory failure. -
Atazanavir-Associated Kidney Stones
The US FDA Adverse Event Reporting System (AERS) was searched for reports of nephrolithiasis in HIV patients receiving atazanavir (ATV)-containing antiretroviral (ARV) regimens; 30 cases were identified.